BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia

Reuters

13 Feb

BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia

Feb 13 (Reuters) - Moleculin Biotech Inc MBRX.O:

MOLECULIN RECEIVES POSITIVE FDA GUIDANCE FOR ACCELERATION OF ITS REGISTRATION-ENABLING MIRACLE TRIAL FOR R/R ACUTE MYELOID LEUKEMIA $(AML.UK)$
MOLECULIN BIOTECH INC - FDA ALLOWS REDUCTION IN SIZE OF MOLECULIN'S PHASE 3 TRIAL
MOLECULIN BIOTECH INC - AMENDED PROTOCOL ALLOWS UNBLINDING OF DATA AT 45 SUBJECTS
MOLECULIN BIOTECH INC - FIRST UNBLINDING EXPECTED IN SECOND HALF OF 2025

Source text: ID:nPn1DNcZga

Further company coverage: MBRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2511523748"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2511523748\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2511523748?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-13 22:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2511523748","market":"us","top_or_hot":-1,"title":"BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia </title></head><body><p><span>Feb 13 (Reuters)</span><span> - </span>Moleculin Biotech Inc <span>MBRX.O</span>:</p><ul><li><p>MOLECULIN RECEIVES POSITIVE FDA GUIDANCE FOR ACCELERATION OF ITS REGISTRATION-ENABLING MIRACLE TRIAL FOR R/R ACUTE MYELOID LEUKEMIA <a href=\"https://laohu8.com/S/AML.UK\">$(AML.UK)$</a></p></li><li><p>MOLECULIN BIOTECH INC - FDA ALLOWS REDUCTION IN SIZE OF MOLECULIN'S PHASE 3 TRIAL</p></li><li><p>MOLECULIN BIOTECH INC - AMENDED PROTOCOL ALLOWS UNBLINDING OF DATA AT 45 SUBJECTS</p></li><li><p>MOLECULIN BIOTECH INC - FIRST UNBLINDING EXPECTED IN SECOND HALF OF 2025</p></li></ul><p>Source text: <span>ID:nPn1DNcZga</span></p><p>Further company coverage: <span>MBRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-13 22:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia </title></head><body><p><span>Feb 13 (Reuters)</span><span> - </span>Moleculin Biotech Inc <span>MBRX.O</span>:</p><ul><li><p>MOLECULIN RECEIVES POSITIVE FDA GUIDANCE FOR ACCELERATION OF ITS REGISTRATION-ENABLING MIRACLE TRIAL FOR R/R ACUTE MYELOID LEUKEMIA <a href=\"https://laohu8.com/S/AML.UK\">$(AML.UK)$</a></p></li><li><p>MOLECULIN BIOTECH INC - FDA ALLOWS REDUCTION IN SIZE OF MOLECULIN'S PHASE 3 TRIAL</p></li><li><p>MOLECULIN BIOTECH INC - AMENDED PROTOCOL ALLOWS UNBLINDING OF DATA AT 45 SUBJECTS</p></li><li><p>MOLECULIN BIOTECH INC - FIRST UNBLINDING EXPECTED IN SECOND HALF OF 2025</p></li></ul><p>Source text: <span>ID:nPn1DNcZga</span></p><p>Further company coverage: <span>MBRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUA94DQQ5:1","article_id":"2511523748","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2511523748","pubTimestamp":1739456946,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia Feb 13 (Reuters) - Moleculin Biotech Inc MBRX.O:MOLECULIN RECEIVES POSITIVE FDA GUIDANCE FOR ACCELERATION OF","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","MBRX":"Moleculin Biotech, Inc."},"translate_title":"BRIEF-Moleculin的R/R急性髓系白血病试验获得FDA积极指导","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MBRX":0.9},"content_text":"BRIEF-Moleculin Receives Positive FDA Guidance For Its Trial For R/R Acute Myeloid Leukemia Feb 13 (Reuters) - Moleculin Biotech Inc MBRX.O:MOLECULIN RECEIVES POSITIVE FDA GUIDANCE FOR ACCELERATION OF ITS REGISTRATION-ENABLING MIRACLE TRIAL FOR R/R ACUTE MYELOID LEUKEMIA $(AML.UK)$MOLECULIN BIOTECH INC - FDA ALLOWS REDUCTION IN SIZE OF MOLECULIN'S PHASE 3 TRIALMOLECULIN BIOTECH INC - AMENDED PROTOCOL ALLOWS UNBLINDING OF DATA AT 45 SUBJECTSMOLECULIN BIOTECH INC - FIRST UNBLINDING EXPECTED IN SECOND HALF OF 2025Source text: ID:nPn1DNcZgaFurther company coverage: MBRX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}